Skip to content
GRDNGuardian Pharmacy Services, Inc.

Earnings

When Guardian Pharmacy Services, Inc. reports, what it reported each quarter, and how the stock took the results.

12 quarters. Sep 30, 2023 to Sep 30, 2026. USD.

Next results · Q4 2026Projected

Mar 10, after the close

Wed, Mar 10, 2027in 112 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Mar 4 – Apr 2

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
$397.62M
Revenue, change from a year earlier: Q3 2026 −1.7%, Q2 2026 +2.2%, Q1 2026 +2.2%, Q4 2025 +17.4%
Net income
$20.92M
Net income, change from a year earlier: Q3 2026 +90.3%, Q2 2026 +142.2%, Q1 2026 +40.7%, Q4 2025 +331.6%
EPS
—
EPS, change from a year earlier: Q3 2026 +93.3%, Q3 2025 n/m

Quarter by quarter

Q3 2026$371.07M−1.7% vs Q3 2025

Latest results

  1. Q3 2026Nov 5, 2026, after the closeThe release+6.2%by the close of Nov 6
    Revenue
    $371.07M
    −1.7%
    Net income
    $18.68M
    +90.3%
    EPS
    $0.29
    +93.3%
    The Company also raised its full-year guidance.
  2. Q2 2026Aug 6, 2026, after the closeThe release+10.5%by the close of Aug 7
    Revenue
    $351.77M
    +2.2%
    Net income
    $21.87M
    +142.2%
    EPS
    —
    —
  3. Q1 2026May 6, 2026, after the closeThe release1.1%by the close of May 7
    Revenue
    $336.60M
    +2.2%
    Net income
    $13.30M
    +40.7%
    EPS
    —
    —
  4. Q4 2025Mar 11, 2026, after the closeThe release2.3%by the close of Mar 12
    Revenue
    $397.62M
    +17.4%
    Net income
    $20.92M
    +331.6%
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 5, 2026 · after-hoursNov 5, 202636 d10-Q$371.07M−1.7%$0.29+6.2%
Q2 2026Jun 30, 2026Aug 6, 2026 · after-hoursAug 6, 202637 d10-Q$351.77M+2.2%—+10.5%
Q1 2026Mar 31, 2026May 6, 2026 · after-hoursMay 6, 202636 d10-Q$336.60M+2.2%—1.1%
FY 2025
Q4 2025derivedDec 31, 2025Mar 11, 2026 · after-hoursMar 11, 202670 d10-K$397.62M+17.4%—2.3%
Q3 2025Sep 30, 2025Nov 10, 2025 · after-hoursNov 10, 202541 d10-Q$377.43M+20.0%$0.15+4.6%
Q2 2025Jun 30, 2025Aug 11, 2025 · after-hoursAug 11, 202542 d10-Q$344.33M+14.8%—+14.0%
Q1 2025Mar 31, 2025May 12, 2025 · after-hoursMay 12, 202542 d10-Q$329.31M+19.6%—4.0%
FY 2024
Q4 2024derivedDec 31, 2024Mar 26, 2025 · after-hoursMar 26, 202585 d10-K$338.57M——+4.3%
Q3 2024Sep 30, 2024Nov 12, 2024 · after-hoursNov 12, 202443 d10-Q$314.39M+19.7%—10.7%
Q2 2024Jun 30, 2024————$300.04M———
Q1 2024Mar 31, 2024————$275.41M———
Earlier years, FY 2023 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 5, 2026071056
10-QAug 6, 2026338074
10-QMay 6, 2026209021
10-KMar 11, 2026102172
10-QNov 10, 2025274298
10-QAug 11, 2025177969
10-QMay 12, 2025117801
10-KMar 26, 2025064082
10-QNov 12, 2024256069

Provenance

ProvenanceData status and checks

Guardian Pharmacy Services, Inc. · CIK 1802255 · Engraved from SEC EDGAR